Drugs
Amar Gajjar: SJ901 offers a new targeted therapeutic approach against pediatric low-grade gliomas.
Photo of Amar Gajjar and Giles Robinson from their Twitter

Amar Gajjar: SJ901 offers a new targeted therapeutic approach against pediatric low-grade gliomas

Quoting Amar Gajjar on Twitter:

”SJ901, named after the last 3 digits of the experimental SpringWorks drug, offers a new targeted therapeutic approach against pediatric low-grade gliomas. Giles Robinson.”

For the article click here.
Source: Amar Gajjar/Twitter

 

Amar Gajjar cancer Giles Robinson gliomas OncoDaily Oncology SpringWorks